Jonathan Hubb

ORCID: 0000-0002-7032-0427
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • HIV Research and Treatment
  • Animal Virus Infections Studies
  • HIV/AIDS drug development and treatment
  • Hepatitis C virus research
  • Plant Virus Research Studies
  • HIV/AIDS Research and Interventions
  • COVID-19 epidemiological studies
  • Viral gastroenteritis research and epidemiology
  • Liver Disease Diagnosis and Treatment
  • Genomics and Phylogenetic Studies
  • Infectious Diseases and Tuberculosis
  • COVID-19 and healthcare impacts
  • CRISPR and Genetic Engineering
  • Inflammasome and immune disorders
  • Herpesvirus Infections and Treatments
  • Tuberculosis Research and Epidemiology
  • Hepatitis B Virus Studies
  • Cancer, Lipids, and Metabolism
  • Immune responses and vaccinations
  • Mycobacterium research and diagnosis
  • Viral Infections and Immunology Research
  • Systemic Lupus Erythematosus Research

Public Health England
2021-2022

Imperial College London
2022

Quadram Institute
2022

ZOE (United Kingdom)
2021

Barts Health NHS Trust
2015-2018

University of Cambridge
2005

Background. An 18-month-old boy developed encephalopathy, for which extensive investigation failed to identify an etiology, 6 weeks after stem cell transplant. To exclude a potential infectious cause, we performed high-throughput RNA sequencing on brain biopsy.

10.1093/cid/ciu940 article EN cc-by-nc-nd Clinical Infectious Diseases 2015-01-07

The ICONIC project has developed an automated high-throughput pipeline to generate HIV nearly full-length genomes (NFLG, i.e. from gag nef) next-generation sequencing (NGS) data. was applied 420 samples collected at University College London Hospitals NHS Trust and Barts Health (London) sequenced using Illumina MiSeq the Wellcome Sanger Institute (Cambridge). Consensus were generated subtyped COMET, unique recombinants studied with jpHMM SimPlot. Maximum-likelihood phylogenetic trees...

10.1371/journal.pone.0192081 article EN cc-by PLoS ONE 2018-02-01

Using deep sequencing, human immunodeficiency virus (HIV) resistance-associated mutations were detected as minority species in the cerebrospinal fluid (CSF) of 4 patients with higher HIV type 1 RNA load CSF than plasma, but not 2 plasma viral load. Deep sequencing could help our understanding escape central nervous system.

10.1093/cid/civ417 article EN Clinical Infectious Diseases 2015-05-28

Abstract Background Drug-resistant minority variants (DRMinVs) detected in patients who recently acquired human immunodeficiency virus type 1 (HIV-1) can be transmitted, generated de novo through replication, or technical errors. The first form is likely to persist and result treatment failure, while the latter two could stochastic transient. Methods Ultradeep sequencing of plasma samples from 835 individuals with recent HIV-1 infection United Kingdom was performed detect DRMinVs at a...

10.1093/cid/ciy1048 article EN Clinical Infectious Diseases 2018-12-06

In subjects with transmitted thymidine analogue mutations (TAMs), boosted PIs (PI/b) are often chosen to overcome possible resistance the NRTI backbone. However, data guide treatment selection limited. Our aim was obtain firmer guidance for clinical practice using real-world cohort data. We analysed 1710 who started a PI/b in combination tenofovir or abacavir plus emtricitabine lamivudine, and compared their virological outcomes those of 4889 patients an NNRTI (predominantly efavirenz),...

10.1093/jac/dky468 article EN cc-by-nc Journal of Antimicrobial Chemotherapy 2018-11-13

Abstract Background & Methods The ICONIC project has developed an automated high-throughput pipeline to generate HIV nearly full-length genomes (NFLG, i.e. from gag nef ) next-generation sequencing (NGS) data. was applied 420 samples collected at University College London Hospital and Barts Health NHS Trust (London) sequenced using Illumina MiSeq the Wellcome Sanger Institute (Cambridge). Consensus were generated subtyped COMET, unique recombinants studied with jpHMM SimPlot....

10.1101/139642 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2017-07-17
Anu Kantele Bradley A. Connor Jay Keystone Manisha Juthani‐Mehta Peter Van Ness and 95 more Joanne M. McGloin Stephanie Argraves Shu Chen Peter Charpentier Laura A. Miller Kathleen Williams Diane Wall Dorothy I. Baker Mary E. Tinetti Peter Peduzzi Vincent Quagliarello Lona Mody Florence Bretelle Patrick Rozenberg Alain Pascal R. Favre Caroline Bohec Anderson Loundou Marie‐Victoire Sénat Germain Aïssi Nathalie Lesavre Julie Brunet Hélène Heckenroth Dominique Luton Didier Raoult Sarah Georgiadou Maria N. Gamaletsou Ioanna Mpanaka Aggeliki Vlachou Andreas V. Goules Dimitrios C. Ziogas Vassiliki Syriou Maria G. Tektonidou Gregory Kaltsas Menelaos N. Manoussakis Nikolaos V. Sipsas Márcia Garnica M Oliveira Cunha Rodrigo Portugal Ângelo Maiolino Arnaldo Lopes Colombo Márcio Nucci Julianne R. Brown Sofia Morfopoulou Jonathan Hubb Warren Emmett Winnie Ip Divya Shah Tony Brooks Simon Paine Glenn Anderson Alex Virasami C. Y. William Tong Duncan A. Clark Vincent Plagnol Thomas S. Jacques Waseem Qasim Michael Hubank Judith Breuer Arianna Calistri Giorgio Palù Eleftherios Mylonakis Cornelius J. Clancy Luis Ostrosky‐Zeichner Kevin W. Garey George Alangaden José A. Vázquez Jeffrey S. Groeger Marc A. Judson Yuka-Marie Vinagre Stephen O. Heard Fainareti N. Zervou Ioannis M. Zacharioudakis Dimitrios P. Kontoyiannis Peter G. Pappas Vicki A. Morrison Gary R. Johnson Kenneth E. Schmader Myron J. Levin Jane Zhang David J. Looney Robert F. Betts Larry Gelb John Guatelli Ruth Harbecke Connie Pachucki Susan Keay Barbara E. Menzies Marie R. Griffin Carol A. Kauffman Adriana Marques John Toney Kathy D. Boardman Shu‐Chih Su Xiaoming Li

Colonized travelers contribute to the pandemic spread of resistant intestinal bacteria.This study is first show that antimicrobial use during travel predisposes

10.1093/cid/ciu1110 article EN Clinical Infectious Diseases 2015-02-24
Coming Soon ...